用实用评分系统预测流感疫苗激发的抗体应答
研究利用佐治亚大学多个流感季节的人体疫苗接种队列数据,开发了简易检测评分(STS)和无检测评分(NTS)两种评分系统,以血凝抑制(HAI)滴度预测疫苗激发的抗体应答。STS在推导队列的AUC为0.943,在2016-2017、2018-2019和2019-2020验证队列分别为0.841、0.936和0.796;NTS推导AUC为0.913,验证队列为0.658至0.875。年龄、种族、BMI、基线HAI滴度和接种史显著影响评分系统表现,且系统在青少年、成人和老年人中表现稳健。
要点
- STS和NTS能区分预测的低、中、高应答组。
- STS推导AUC为0.943,验证队列AUC为0.796至0.936。
- NTS推导AUC为0.913,验证数据集AUC为0.658至0.875。
核心结论
- 成功开发并验证了两种实用评分系统,用于预测个体水平的流感疫苗激发的抗体应答。
- 这些系统可促进个性化疫苗接种建议、政策制定和流感疫苗接种项目的资源分配。
- 所提出的评分系统也是锁定最可能从流感疫苗接种中获益人群的有价值工具。
研究设计与样本
- 利用佐治亚大学(UGA)多个流感季节的人体疫苗接种队列数据,开发了简易检测评分(STS)和无检测评分(NTS)两种评分系统。
- 数据来自四个流感季节(2016-2017至2019-2020),用于模型开发和验证。
- 评分系统预测以血凝抑制(HAI)滴度测量的疫苗激发的抗体应答。
主要发现
- STS和NTS在区分预测的低、中、高应答组方面表现出良好性能。
- STS的AUC值:推导队列为0.943;验证队列2016-2017为0.841,2018-2019为0.936,2019-2020为0.796。
- NTS的AUC值:推导队列为0.913;验证数据集为0.658至0.875。
- 年龄、种族、BMI、基线HAI滴度和接种史显著影响评分系统的表现。
- 评分系统在年龄组(青少年、成人和老年人)中表现出稳健性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Influenza vaccination plays a crucial role in reducing morbidity and mortality from influenza. However, its effectiveness varies due to multiple factors. Reliable point systems combining age, sex, BMI, vaccination history, and other baseline characteristics could aid in making evidence-based decisions regarding influenza vaccination. METHODS: Using human vaccination cohort data from the University of Georgia (UGA) over multiple influenza seasons, we developed two point systems: the Simple-Test score (STS) and the No-Test score (NTS). These scores predict vaccine-elicited antibody responses measured by hemagglutination inhibition (HAI) titers. Data from four influenza seasons (2016-2017 to 2019-2020) were used for model development and validation. RESULTS: The STS and NTS demonstrated good performance in discriminating between predicted lower-, moderate-, and higher-response groups. The AUC values for the STS were 0.943 for derivation and 0.841, 0.936, and 0.796 from the validation cohorts for 2016-2017, 2018-2019, and 2019-2020, respectively. Age, race, BMI, baseline HAI titers, and vaccination history significantly influenced the point system's performance. The point system showed robustness across age groups (teenagers, adults, and elderly). The AUC values for the NTS were 0.913 for derivation and 0.658 to 0.875 for validation datasets. CONCLUSION: We successfully developed and validated two practical point systems to predict individual-level influenza vaccine-elicited antibody responses. These systems could facilitate personalized vaccination recommendations, policymaking, and resource allocation in influenza vaccination programs. The proposed point system is also a valuable tool for targeting populations that are likely to benefit most from influenza vaccination.
引用
- Shen Y, Sung MH, Ge Y, et al. Predicting influenza vaccine-elicited antibody responses with practical point systems. Vaccine. 2025. PMID: 40961797. doi:10.1016/j.vaccine.2025.127737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。